BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2878745)

  • 81. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism.
    Cortes D; Thorup J; Visfeldt J
    J Urol; 2000 Apr; 163(4):1290-2. PubMed ID: 10737531
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Surgical aspects of hormone therapy in cryptorchism].
    Kees A
    Padiatr Padol; 1986; 21(4):389-96. PubMed ID: 2882460
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapeutic effects of luteinizing hormone releasing hormone (LH-RH) in cryptorchidism.
    Bartsch G; Frick J
    Andrologia; 1974; 6(3):197-201. PubMed ID: 4155253
    [No Abstract]   [Full Text] [Related]  

  • 84. Treatment of cryptorchidism by intranasal synthetic LH-RH and its analogue D-Ser(TBU)6-LHRH-EA10.
    Cacciari E; Fréjaville E; Becca A
    Eur J Pediatr; 1982 Dec; 139(4):280-4. PubMed ID: 6133756
    [No Abstract]   [Full Text] [Related]  

  • 85. LH and FSH response to synthetic LHRH after consecutive administration of clomiphene citrate in normal males.
    Hashimoto T; Miyai K; Matsumoto K; Izumi K; Kumahara Y
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1110-2. PubMed ID: 1107347
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Undescended testis histology correlation with adult hormone levels and semen analysis.
    Kraft KH; Canning DA; Snyder HM; Kolon TF
    J Urol; 2012 Oct; 188(4 Suppl):1429-35. PubMed ID: 22906677
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Studies on the endocrine function of the pituitary-testicular axis, with special reference to the diagnosis of pituitary-testicular dysfunction and therapeutic effect of LH-RH analog].
    Tatara K
    Nihon Hinyokika Gakkai Zasshi; 1982 Jul; 73(7):917-28. PubMed ID: 6128437
    [No Abstract]   [Full Text] [Related]  

  • 88. Elevation of serum testosterone during chronic LHRH agonist treatment in the bull.
    Melson BE; Brown JL; Schoenemann HM; Tarnavsky GK; Reeves JJ
    J Anim Sci; 1986 Jan; 62(1):199-207. PubMed ID: 3007418
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Cryptorchism. Treatment with human chorionic gonadotropin or gonadotropin-releasing hormone?].
    Christiansen P; Müller JR; Buhl SB; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PI; Kastrup KW; Nielsen K; Nielsen LB
    Ugeskr Laeger; 1993 Oct; 155(41):3287-90. PubMed ID: 7903008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Changes in plasma levels of LH, FSH and testosterone following the administration of synthetic luteinizing hormone-releasing hormone to cryptorchid patients.
    Matsuda S; Shirai M; Mitsukawa S; Nakamura M; Yonezawa K
    Tohoku J Exp Med; 1975 Aug; 116(4):327-32. PubMed ID: 242097
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gonadotropin secretion in prepubertal and pubertal primary hypogonadism: response to LHRH.
    de Behar BR; Mendilaharzu H; Rivarola MA; Bergadá C
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1070-5. PubMed ID: 1107345
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of cryptorchidism with pulsatile luteinizing hormone-releasing hormone (LH-RH).
    Keogh EJ; MacKellar A; Mallal SA; Dunn AG; McColm SC; Somerville CP; Glatthaar C; Marshall T; Attikiouzel J
    J Pediatr Surg; 1983 Jun; 18(3):282-3. PubMed ID: 6135766
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pituitary LH and FSH and testosterone secretion in infants with undescended testes.
    Job JC; Gendrel D; Safar A; Roger M; Chaussain JL
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):644-9. PubMed ID: 17259
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Testicular descent: when to interfere?
    Hamza AF; Elrahim M; Elnagar ; Maaty SA; Bassiouny E; Jehannin B
    Eur J Pediatr Surg; 2001 Jun; 11(3):173-6. PubMed ID: 11475113
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
    Oka H; Negoro H; Sugino Y; Iwamura H; Moroi S; Kawakita M
    Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Experiences with Kryptocur in the treatment of cryptorchism.
    Végh A
    Acta Chir Hung; 1987; 28(4):257-61. PubMed ID: 2893501
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.
    Bica DT; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S38-42. PubMed ID: 8101813
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Signs of sexual behaviour are not increased after subchronic treatment with LHRH in young men.
    Perras B; Smolnik R; Fehm HL; Born J
    Psychoneuroendocrinology; 2001 Jan; 26(1):1-15. PubMed ID: 11070330
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of adjunctive hormonal therapy on testicular descent and spermatogenic function among children with cryptorchidism: a systematic review and meta-analysis.
    Zhang K; Zhang Y; Chao M
    Hormones (Athens); 2021 Mar; 20(1):119-129. PubMed ID: 33123977
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Treatment of cryptorchidism with low doses of buserelin over a 6-months period.
    Hadziselimovic F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S56-8. PubMed ID: 2891526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.